Centogene AG

centogene engages in diagnosis and research around rare diseases transforming real-world clinical, genetic, and multiomic data to diagnose, understand, and treat rare diseases. our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our extensive rare disease knowledge and data. centogene has developed a global proprietary rare disease platform based on our real-world data repository of over 650,000 individuals representing over 120 different countries. the company’s platform includes epidemiologic, phenotypic, and genetic data that reflects a global population, as well as a biobank of patients’ blood samples and cell cultures. centogene believes this represents the only platform focused on comprehensive analysis of multi-level data to improve the understanding of rare hereditary diseases. it allows for better identification and stratification of patients and their underlying diseases to enable and accelerate discovery, development, and access to orphan drugs. as of december 31, 2021, the company collaborated with over 30 pharmaceutical partners.

البحث عن عناوين البريد الإلكتروني

جربها بسرعة مع tomba.io. tomba.io.

ابحث عن عناوين البريد الإلكتروني من القائمةابدأ مع جوجل